Literature DB >> 2948967

Demonstration of a keratan sulfate proteoglycan and a mannose-rich glycoconjugate in corpora amylacea of the brain by immunocytochemical and lectin-binding methods.

H M Liu, K Anderson, B Caterson.   

Abstract

The aim of the present report is to call attention to the fact that corpora amylacea (CA) of the brain have similar biochemical and immunological characteristics as the connective tissue matrix. We have demonstrated that CA reacted positively toward a monoclonal antibody that specifically recognized the polysaccharide determinant on cartilage proteoglycans. Material strongly bound to concanavalin A was demonstrated in CA, blood vessel wall and cartilage and suggested high levels of mannose in these structures. These findings are in agreement with the known fact that both brain and cartilage contain keratan sulfate and high mannose glycoproteins. We propose that CA may result from accumulation of glycoconjugates normally present in the brain tissue matrix as the result of aging.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 2948967     DOI: 10.1016/0165-5728(87)90100-7

Source DB:  PubMed          Journal:  J Neuroimmunol        ISSN: 0165-5728            Impact factor:   3.478


  10 in total

1.  Localization of blood proteins thrombospondin1 and ADAMTS13 to cerebral corpora amylacea.

Authors:  He Meng; Xiaojie Zhang; Mila Blaivas; Michael M Wang
Journal:  Neuropathology       Date:  2009-04-28       Impact factor: 1.906

2.  Immunochemical characterization and ultrastructural localization of chondroitin sulfates and keratan sulfate in embryonic chick bone marrow.

Authors:  J M Sorrell; F Mahmoodian; B Caterson
Journal:  Cell Tissue Res       Date:  1988-06       Impact factor: 5.249

3.  Identification of cellular and extracellular sites of amyloid precursor protein extracytoplasmic domain in normal and Alzheimer disease brains.

Authors:  B Tate-Ostroff; R E Majocha; C A Marotta
Journal:  Proc Natl Acad Sci U S A       Date:  1989-01       Impact factor: 11.205

4.  Immunoreactivity of canine and feline polyglucosan bodies for monoclonal antibody against human polyglucosan.

Authors:  S Kamiya; Y Suzuki; M Daigo
Journal:  Acta Neuropathol       Date:  1990       Impact factor: 17.088

5.  Immunohistochemical localization of articular cartilage proteoglycan and link protein in situ using monoclonal antibodies and lectin-binding methods.

Authors:  S Hoedt-Schmidt; J McClure; M K Jasani; D A Kalbhen
Journal:  Histochemistry       Date:  1993-05

6.  Immunolocalization of proteoglycan types in aortas of pigeons with spontaneous or diet-induced atherosclerosis.

Authors:  R A Robbins; W D Wagner; L M Sawyer; B Caterson
Journal:  Am J Pathol       Date:  1989-03       Impact factor: 4.307

7.  Corpora Amylacea of Brain Tissue from Neurodegenerative Diseases Are Stained with Specific Antifungal Antibodies.

Authors:  Diana Pisa; Ruth Alonso; Alberto Rábano; Luis Carrasco
Journal:  Front Neurosci       Date:  2016-03-08       Impact factor: 4.677

8.  Cerebral Corpora amylacea are dense membranous labyrinths containing structurally preserved cell organelles.

Authors:  Paula P Navarro; Christel Genoud; Daniel Castaño-Díez; Alexandra Graff-Meyer; Amanda J Lewis; Yvonne de Gier; Matthias E Lauer; Markus Britschgi; Bernd Bohrmann; Stephan Frank; Jürgen Hench; Gabriel Schweighauser; Annemieke J M Rozemuller; Wilma D J van de Berg; Henning Stahlberg; Sarah H Shahmoradian
Journal:  Sci Rep       Date:  2018-12-21       Impact factor: 4.379

9.  Exploring the elusive composition of corpora amylacea of human brain.

Authors:  Elisabet Augé; Jordi Duran; Joan J Guinovart; Carme Pelegrí; Jordi Vilaplana
Journal:  Sci Rep       Date:  2018-09-10       Impact factor: 4.379

10.  Corpora amylacea act as containers that remove waste products from the brain.

Authors:  Marta Riba; Elisabet Augé; Joan Campo-Sabariz; David Moral-Anter; Laura Molina-Porcel; Teresa Ximelis; Ruth Ferrer; Raquel Martín-Venegas; Carme Pelegrí; Jordi Vilaplana
Journal:  Proc Natl Acad Sci U S A       Date:  2019-12-03       Impact factor: 11.205

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.